A detailed history of Huntington National Bank transactions in Moderna, Inc. stock. As of the latest transaction made, Huntington National Bank holds 1,204 shares of MRNA stock, worth $49,857. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,204
Previous 1,792 32.81%
Holding current value
$49,857
Previous $212,000 62.26%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$63.64 - $125.14 $37,420 - $73,582
-588 Reduced 32.81%
1,204 $80,000
Q2 2024

Aug 08, 2024

BUY
$101.21 - $166.61 $25,100 - $41,319
248 Added 16.06%
1,792 $212,000
Q1 2024

May 03, 2024

BUY
$85.37 - $115.44 $33,123 - $44,790
388 Added 33.56%
1,544 $164,000
Q4 2023

Feb 07, 2024

SELL
$69.51 - $104.43 $85,427 - $128,344
-1,229 Reduced 51.53%
1,156 $114,000
Q3 2023

Nov 08, 2023

SELL
$96.41 - $126.61 $15,522 - $20,384
-161 Reduced 6.32%
2,385 $246,000
Q2 2023

Aug 11, 2023

BUY
$118.5 - $160.53 $39,697 - $53,777
335 Added 15.15%
2,546 $309,000
Q1 2023

May 10, 2023

BUY
$135.66 - $197.02 $92,791 - $134,761
684 Added 44.79%
2,211 $339,000
Q4 2022

Feb 09, 2023

BUY
$118.38 - $210.04 $60,965 - $108,170
515 Added 50.89%
1,527 $274,000
Q3 2022

Nov 07, 2022

BUY
$118.07 - $194.18 $16,411 - $26,991
139 Added 15.92%
1,012 $120,000
Q2 2022

Aug 09, 2022

SELL
$117.13 - $176.59 $25,651 - $38,673
-219 Reduced 20.05%
873 $124,000
Q1 2022

May 10, 2022

BUY
$126.46 - $235.05 $78,405 - $145,731
620 Added 131.36%
1,092 $188,000
Q4 2021

Jan 21, 2022

BUY
$225.82 - $368.51 $34,550 - $56,382
153 Added 47.96%
472 $119,000
Q3 2021

Oct 28, 2021

BUY
$221.9 - $484.47 $17,530 - $38,273
79 Added 32.92%
319 $122,000
Q1 2021

Apr 12, 2021

SELL
$109.18 - $185.98 $12,009 - $20,457
-110 Reduced 31.43%
240 $31,000
Q3 2020

Oct 30, 2020

BUY
$54.34 - $94.85 $13,585 - $23,712
250 Added 250.0%
350 $25,000
Q2 2020

Jul 30, 2020

BUY
$29.67 - $80.0 $2,967 - $8,000
100 New
100 $6,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.2B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.